Vertical variation in flight activity of the lesser short-tailed bat in podocarp and beech forests, Central North Island, New Zealand

Designing robust monitoring programmes for cryptic species is particularly difficult. Not detecting a species does not necessarily mean that it is absent from the sampling area. A conclusion of absence made in error can lead to misguided inferences about distribution, colonisation and local extinction estimates, which in turn affects where and how conservation actions are undertaken. It is therefore important to investigate monitoring techniques that reduce the non-detection rate of cryptic species. As habitat complexity plays an important role in the activity of bats within a forest, it was hypothesised that the amount of vegetative ‘clutter’ present at different heights within two different forest types affected the flight activity of lesser short-tailed bats (Mystacina tuberculata). This could affect detection of the species within different forest structures. To compare bat activity at three heights – top (22.0–25.0 m), middle (10.0–12.0 m) and bottom (1.5–2.0 m) – within a podocarp and a beech forest we used automatic bat monitors during January to March 2005. The number of bat passes was recorded at each height at two study areas within each forest and compared between forest types. The forest structure was described using the Recce method and vegetative cover estimated within the three height tiers sampled for bat activity. Within both forest types, the middle-level bat detectors logged the greatest amount of activity. However, differences between the forest types were most pronounced closer to the ground, where a high amount of activity was detected within the beech forest, and very little within the podocarp forest. This suggests that flight activity of lesser short-tailed bats may be affected by the level of vegetative clutter found at different heights within a forest. When designing monitoring programmes for lesser short-tailed bats, it is recommended that consideration be given to the forest structure and how this may affect detection of bat activity

TartanSW : filling the information gap in standing wave microscopy

Widefield standing wave microscopy has been shown to provide axial resolutions below 100 nm that can be acquired at up to 100 frames per second with the only change to the imaging setup being there placement of a standard microscope slide with a first surface reflector[1,2]. However, because this technique makes use of the interaction between a fluorescent specimen and the antinodal planes of an optical standing wave to achieve axial super-resolution the nodal plane contributions result in ~50% of the specimen not being imaged. We present a method called TartanSW which makes use of standing waves of different wavelengths to shift the antinodal plane axial locations and hence reduce the amount of missing axial information in the mage

Optical mesoscopy, machine learning and computational microscopy enable high information content diagnostic imaging of blood films

Automated image-based assessment of blood films has tremendous potential to support clinical haematology within overstretched healthcare systems. To achieve this, efficient and reliable digital capture of the rich diagnostic information contained within a blood film is a critical first step. However, this is often challenging, and in many cases entirely unfeasible, with the microscopes typically used in haematology due to the fundamental trade-off between magnification and spatial resolution. To address this, we investigated three state-of-the-art approaches to microscopic imaging of blood films which leverage recent advances in optical and computational imaging and analysis to increase the information capture capacity of the optical microscope: optical mesoscopy, which uses a giant microscope objective (Mesolens) to enable high resolution imaging at low magnification; Fourier ptychographic microscopy, a computational imaging method which relies on oblique illumination with a series of LEDs to capture high resolution information; and deep neural networks which can be trained to increase the quality of low magnification, low resolution images. We compare and contrast the performance of these techniques for blood film imaging for the exemplar case of Giemsa-stained peripheral blood smears. Using computational image analysis and shape-based object classification we demonstrate their use for automated analysis of red blood cell morphology and visualization and detection of small blood borne parasites such as the malarial parasite Plasmodium falciparum. Our results demonstrate that these new methods greatly increase the information capturing capacity of the light microscope with transformative potential for haematology and more generally across digital pathology. This article is protected by copyright. All rights reserved

Addressing Profound Disadvantages to Improve Indigenous Health and Reduce Hospitalisation: A Collaborative Community Program in Remote Northern Territory

BACKGROUND: Aboriginal people in rural and remote areas of the Northern Territory of Australia have suffered longstanding issues of homelessness and profound health and social inequities. The town and region of Katherine are particularly impacted by such inequities and have the highest rates of homelessness in Australia, composed almost entirely of Aboriginal people who represent 51% of the total population of 24,000 people. The region is serviced by a 60-bed hospital, and a small cohort of frequent attenders (FAs) represent 11% of the Emergency Department (ED) case load. The vast majority of FAs are Aboriginal and have very high burdens of social inequity and homelessness. FAs are a challenge to efficient and effective use of resources for most hospitals around the world, and investment in programs to address underlying social and chronic health issues contributing to frequent attendance have been demonstrated to be effective. METHODS: These are the interim findings of a prospective cohort study using five sources of linked health and related data to evaluate a community-based case management pilot in a culturally competent framework to support frequent attenders to the Katherine Hospital ED. FAs were defined as people with six or more presentations in 12 preceding months. The intervention composed of a community-based case management program with a multi-agency service delivery addressing underlying vulnerabilities contributing to ED presentations. RESULTS: Among this predominantly Aboriginal cohort (91%), there were high rates of homelessness (64%), food insecurity (60%) and alcohol misuse (64%), limited access to transport, and complex comorbidities (average of 2.8 chronic conditions per client). Following intervention, there was a statistically significant reduction in ED presentations (IRR 0.77, 95% CI 0.69-0.85), increased engagement with primary health care (IRR 1.90, 95% CI 1.78-2.03), and ambulance utilisation (IRR 1.21, 95% CI 1.07-1.38). Reductions in hospital admissions (IRR 0.93, 95% CI 0.77-1.10) and aeromedical retrievals (IRR 0.67, 95% CI 0.35-1.20) were not statistically significant. CONCLUSIONS: This study demonstrates the short-term impacts of community-led case management extending beyond the hospital setting, to address causes of recurrent ED presentations among people with complex social and medical backgrounds. Improving engagement with primary care is a particularly important outcome given the national impetus to reduce preventable hospital admissions

SLN124, a GalNAc conjugated 19-mer siRNA targeting tmprss6, reduces plasma iron and increases hepcidin levels of healthy volunteers

SLN124, an N-acetylgalactosamine conjugated 19-mer short interfering RNA, is being developed to treat iron-loading anemias (including beta-thalassemia and myelodysplastic syndromes) and myeloproliferative neoplasms (polycythemia vera). Through hepatic targeting and silencing of the TMPRSS6 gene, SLN124 increases endogenous hepcidin synthesis. This is the first clinical report of an siRNA targeting a component of iron homeostasis. This first-in-human, phase 1 study assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of SLN124 (1.0, 3.0, and 4.5 mg/kg) in healthy volunteers. Twenty-four participants were randomized in three sequential cohorts of eight subjects, each to receive a single dose of either SLN124 or placebo (6:2 randomization), administered subcutaneously. There were no serious or severe adverse events, or discontinuations due to adverse events, and most treatment-emergent adverse events were mild, including transient mild injection site reactions, resolving without intervention. SLN124 was rapidly absorbed, with a median tmax of 4–5 h across all treatment groups, and largely eliminated from plasma by 48 h. Plasma concentrations increased in a greater than dose proportional fashion between treatment groups. In all SLN124 groups, a dose-related effect was observed across iron metabolism markers, and across erythroid markers, SLN124 resulted in increased plasma hepcidin levels, peaking around Day 29, and consequent dose-related sustained reductions in plasma iron and transferrin saturation with decreased reticulocyte production, MCHC, and MCV. Results suggest duration of action lasting up to 56 days after a single SLN124 dose, on hepcidin and hematological parameters of iron metabolism (serum iron and TSAT)